GROUP EXECUTIVES

Stephen Bradley Saad (52)
Aspen Group Chief Executive
Qualifications: CA(SA)
Appointed: January 1999
Stephen is a founding shareholder of the Aspen Group and his responsibilities extend to include the strategic positioning and global transactions, geographic expansion and product diversification of Aspen in developed and emerging markets as a leading multinational pharmaceutical company.

Gus Attridge (55)
Aspen Deputy Group Chief Executive
Qualifications: CA(SA)
Appointed: January 1999
Gus is a founding shareholder of the Aspen Group and is responsible for the strategic and financial well-being of the Group while also identifying and pursuing appropriate corporate opportunities and global transactions that will further benefit the Group and its stakeholders in its pursuance of global pharmaceutical leadership status.

Sean Capazorio (50)
Aspen Group Finance Officer
Qualifications: BComm, CA(SA)
Appointed: January 1999
Sean takes responsibility for the Group’s finance portfolio across Aspen’s 60 businesses and he is also intricately involved in strategic global transactions.

Carlos Fabián Abelleyra Cordero (54)
Aspen CEO Spanish Latin America
Qualifications: BBA
Appointed: July 2013
Carlos manages Aspen’s business units in Spanish Latin America which comprise Argentina, Chile, Colombia, Ecuador, Mexico, Panama, Peru, the Caribbean and Central America, as well as the Nutritional and Pharma manufacturing facilities in the region.

Dennis Dencher (43)
Aspen CEO Commercial Business Europe
Qualifications: BComm
Appointed: October 2015
Dennis joined Aspen in October 2015. He is responsible for the commercial operations in 45 countries in Europe CIS, which encompasses a net sales turnover of approximately EUR 700 million and a team of some 600 employees.

Noel Guliwe (53)
Aspen Pharmacare CEO - South Africa
Qualifications: BPharm
Appointed: January 2009
Noel joined Aspen in January 2009 and he currently heads up the South African Commercial business.

Lorraine Hill (53)
Aspen Group Operating Officer
Qualifications: BPharm
Appointed: January 1999
Lorraine is responsible for multiple operational areas of the business including regulatory affairs, quality, pharmacovigilence, new product development, manufacturing and supply chain, procurement and third party supply, negotiation and implementation of new business initiatives including global transactions, IT and Group project management.

Samer Kassem (42)
CEO Aspen Global Incorporated
Qualifications: CMA, CFM, CBM, MBA
Appointed: May 2008
Samer joined the Group to set up the global business in Mauritius. He has since assisted in the negotiation, completion and integration of strategic acquisitions as well as establishing commercial operations in countries in Latin America, the Middle East and North Africa in addition to the United States. Samer is also responsible for the Intellectual Property and supply chain of the global brands.

Trevor Ziman (45)
Aspen Asia Pacific CEO
Qualifications: BComm, Dip Acc, CA(SA), CA(Aus)
Appointed: May 2001
Trevor joined the Group as a founder director of Aspen Australia in May 2001 to manage the businesses financial and commercial affairs. He has since assisted in the completion and integration of strategic acquisitions as well as establishing operations in the Philippines, Taiwan, Malaysia, Japan and Hong Kong. In 2014 Trevor was promoted to the position of CEO and more recently he contributed toward establishing Aspen’s operations in China. This region has some 1600 employees.